These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 24321564)

  • 21. The forces driving clonal expansion of the HIV-1 latent reservoir.
    Liu R; Simonetti FR; Ho YC
    Virol J; 2020 Jan; 17(1):4. PubMed ID: 31910871
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Concerted action of cellular JNK and Pin1 restricts HIV-1 genome integration to activated CD4+ T lymphocytes.
    Manganaro L; Lusic M; Gutierrez MI; Cereseto A; Del Sal G; Giacca M
    Nat Med; 2010 Mar; 16(3):329-33. PubMed ID: 20173753
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIV-1 DNA burden in peripheral blood CD4+ cells influences disease progression, antiretroviral efficacy, and CD4+ T-cell restoration.
    Russell RR; Bowmer MI; Nguyen C; Grant MD
    Viral Immunol; 2001; 14(4):379-89. PubMed ID: 11792067
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HIV latency and integration site placement in five cell-based models.
    Sherrill-Mix S; Lewinski MK; Famiglietti M; Bosque A; Malani N; Ocwieja KE; Berry CC; Looney D; Shan L; Agosto LM; Pace MJ; Siliciano RF; O'Doherty U; Guatelli J; Planelles V; Bushman FD
    Retrovirology; 2013 Aug; 10():90. PubMed ID: 23953889
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo fate of HIV-1-infected T cells: quantitative analysis of the transition to stable latency.
    Chun TW; Finzi D; Margolick J; Chadwick K; Schwartz D; Siliciano RF
    Nat Med; 1995 Dec; 1(12):1284-90. PubMed ID: 7489410
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD4 T cell nadir independently predicts the magnitude of the HIV reservoir after prolonged suppressive antiretroviral therapy.
    Boulassel MR; Chomont N; Pai NP; Gilmore N; Sékaly RP; Routy JP
    J Clin Virol; 2012 Jan; 53(1):29-32. PubMed ID: 22019250
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of HIV integration in viral persistence: no more whistling past the proviral graveyard.
    Maldarelli F
    J Clin Invest; 2016 Feb; 126(2):438-47. PubMed ID: 26829624
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deficiency in DNA damage response, a new characteristic of cells infected with latent HIV-1.
    Piekna-Przybylska D; Sharma G; Maggirwar SB; Bambara RA
    Cell Cycle; 2017 May; 16(10):968-978. PubMed ID: 28388353
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dual role of the chromatin-binding factor PHF13 in the pre- and post-integration phases of HIV-1 replication.
    Hofmann S; Dehn S; Businger R; Bolduan S; Schneider M; Debyser Z; Brack-Werner R; Schindler M
    Open Biol; 2017 Oct; 7(10):. PubMed ID: 29021215
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lentivirus-associated MAPK/ERK2 phosphorylates EMD and regulates infectivity.
    Bukong TN; Hall WW; Jacqué JM
    J Gen Virol; 2010 Sep; 91(Pt 9):2381-92. PubMed ID: 20463147
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The multifactorial nature of HIV-1 latency.
    Lassen K; Han Y; Zhou Y; Siliciano J; Siliciano RF
    Trends Mol Med; 2004 Nov; 10(11):525-31. PubMed ID: 15519278
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Experimental approaches to the study of HIV-1 latency.
    Han Y; Wind-Rotolo M; Yang HC; Siliciano JD; Siliciano RF
    Nat Rev Microbiol; 2007 Feb; 5(2):95-106. PubMed ID: 17224919
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Viral latency and potential eradication of HIV-1.
    Matreyek KA; Oztop I; Freed EO; Engelman A
    Expert Rev Anti Infect Ther; 2012 Aug; 10(8):855-7. PubMed ID: 23030323
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HIV integration site distributions in resting and activated CD4+ T cells infected in culture.
    Brady T; Agosto LM; Malani N; Berry CC; O'Doherty U; Bushman F
    AIDS; 2009 Jul; 23(12):1461-71. PubMed ID: 19550285
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy.
    Finzi D; Hermankova M; Pierson T; Carruth LM; Buck C; Chaisson RE; Quinn TC; Chadwick K; Margolick J; Brookmeyer R; Gallant J; Markowitz M; Ho DD; Richman DD; Siliciano RF
    Science; 1997 Nov; 278(5341):1295-300. PubMed ID: 9360927
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of protein kinase C theta inhibitors for the control of HIV-1 replication in human CD4+ T cells reveals an effect on retrotranscription in addition to viral transcription.
    Bermejo M; López-Huertas MR; Hedgpeth J; Mateos E; Rodríguez-Mora S; Maleno MJ; Plana M; Swindle J; Alcamí J; Coiras M
    Biochem Pharmacol; 2015 Apr; 94(4):241-56. PubMed ID: 25732195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HIV-1 latency and virus production from unintegrated genomes following direct infection of resting CD4 T cells.
    Chan CN; Trinité B; Lee CS; Mahajan S; Anand A; Wodarz D; Sabbaj S; Bansal A; Goepfert PA; Levy DN
    Retrovirology; 2016 Jan; 13():1. PubMed ID: 26728316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Host factors regulating post-integration latency of HIV.
    Williams SA; Greene WC
    Trends Microbiol; 2005 Apr; 13(4):137-9. PubMed ID: 15817380
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of human immunodeficiency virus-1 latency and its reactivation.
    Verdin E
    Bull Mem Acad R Med Belg; 2008; 163(6):355-64; discussion 364-5. PubMed ID: 19445107
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dual role of prostratin in inhibition of infection and reactivation of human immunodeficiency virus from latency in primary blood lymphocytes and lymphoid tissue.
    Biancotto A; Grivel JC; Gondois-Rey F; Bettendroffer L; Vigne R; Brown S; Margolis LB; Hirsch I
    J Virol; 2004 Oct; 78(19):10507-15. PubMed ID: 15367617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.